Friday , March 5 2021

Conte will use “all legal remedies” against Pfizer and AstraZeneco due to delays in the supply of vaccines

The European Union is facing growing vaccine problems.  Photo: Reuters

The European Union is facing growing vaccine problems. Photo: Reuters

The British pharmaceutical company, which is developing the vaccine in conjunction with Oxford University, will ship a total of just 31 million doses of covid-19 vaccine across the EU over the first three months of this year. The reason is the production problems of its factory in Belgium, which is otherwise managed by the partner company Novasep. They were not available for comment.

AstraZeneca is expected to deliver 80 million doses of the vaccine to the 27 EU countries by the end of March. The first doses will arrive in the countries, it was agreed, after February 15.

This is another serious blow for Member States, which have also had to change their vaccination plans due to the temporary reduction in the supply of Comirnaty, a vaccine produced in a Belgian factory by the American pharmaceutical company Pfizer. .

“The initial number of doses will be lower due to reduced production in our European supply chain. However, in February and March, glass production will increase, bringing millions of doses to the EU,” he said. to say. The representative of AstraZeneca wrote in a written message. The promised and planned 80 million doses of the vaccine are expected to be delivered to the EU during the second quarter.

Italy announces the use of legal remedies
Italian Prime Minister Giuseppe Conte attacked vaccine manufacturers and deemed the delays unacceptable, announcing the use of “all available remedies for serious breaches of contract”. Due to supply problems, Italy will have to change its entire vaccination strategy, a health official warned. Due to the delay in the delivery of Pfizer vaccines, the volume of vaccination in Rome had to be reduced by two thirds. About 1.31 million doses of the vaccine have been used so far in Italy, which is about 70% of all doses received, placing Italy in second place in the EU, just behind Germany.

AstraZeneca will deliver the first shipments after February 15, but many of them will be smaller than promised.  Photo: Reuters

AstraZeneca will deliver the first shipments after February 15, but many of them will be smaller than promised. Photo: Reuters

Growing dissatisfaction

EU officials responded to the news with anger and unease. European Commissioner for Health Stella Kyriakides he tweeted yes “European governments have expressed great dissatisfaction.” Austrian media reported that they would receive only 600,000 of AstraZeneca’s promised two million doses by the end of March, with the remaining 1.4 million scheduled for April.

The first 40 million doses for the poorest countries
The World Health Organization has announced that 20 percent of the most vulnerable populations are expected to be vaccinated in the poorest countries under the Covax plan this year. The WHO has reached an agreement with Pfizer to supply 40 million doses to the poorest countries in February and the British company AstraZeneca is expected to supply another 150 million doses in the first quarter of this year. A Chinese and Russian vaccine could then be included in the Covax plan.

The vaccine is expected to be approved by the EMA on January 29

The European Medicines Agency (EMA) must approve AstraZeneca before it can be used. The EMA will decide on this on 29 January, but the vaccine has already been provisionally authorized for use in some other countries, such as the United Kingdom. AstraZeneca also sent on Friday the first major shipment of the vaccine to some non-European countries, such as Mali and Brazil.

Brussels has an agreement with AstraZeneca to buy at least 300 million doses of the vaccine with the possibility of an additional one hundred million. The company is expected to produce more than three billion doses of covida vaccine. With Pfizer, the EU has agreed to buy 600 million doses.

President of the European Commission Ursula von der Leyen despite the complications, it still expects 70% of the Union’s population to be vaccinated by the summer.

Source link